Inflammatory processes play a pivotal role in the pathogenesis of atherosclerosis and
mediate many of the stages of atheroma development from initial leukocyte recruitment to …

The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Background: Vascular injury and inflammation during percutaneous coronary intervention
(PCI) are associated with increased risk of post-PCI adverse outcomes. Colchicine …

Background Dietary interventions may play a role in secondary cardiovascular prevention.
hsCRP (High‐sensitivity C‐reactive protein) is a marker of risk for major adverse …

High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that predicts incident
myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death among …

composed of those with normal or low levels of LDL-C. As shown in Figure 3 in data from the
large-scale Women's Health Study, apparently healthy individuals with low levels of LDL-C …

During the past three decades, percutaneous coronary intervention has become one of the
cardinal treatment strategies for stenotic coronary artery disease. Technical advances …

Diabetes represents a major cause of cardiovascular morbidity and mortality in developed
countries, and atherothrombosis accounts for most deaths among diabetics. Recent …

The classical acute-phase protein, C-reactive protein (CRP), is an exquisitely sensitive
systemic marker of disease with broad clinical utility for monitoring and differential diagnosis …

Background—Previous studies suggested that statin pretreatment reduces cardiac events in
patients undergoing percutaneous coronary intervention. However, most data were …